Israel · Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 717.05 million. The enterprise value is 521.50 million.
| Market Cap | 717.05M |
| Enterprise Value | 521.50M |
Important Dates
The last earnings date was Tuesday, November 25, 2025.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 13.03% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 16.03.
| PE Ratio | 16.03 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | 8.37 |
| P/OCF Ratio | 6.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.79, with an EV/FCF ratio of 6.09.
| EV / Earnings | 11.95 |
| EV / Sales | 0.57 |
| EV / EBITDA | 5.79 |
| EV / EBIT | 12.51 |
| EV / FCF | 6.09 |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.86 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.57 |
| Interest Coverage | 20.37 |
Financial Efficiency
Return on equity (ROE) is 6.79% and return on invested capital (ROIC) is 4.41%.
| Return on Equity (ROE) | 6.79% |
| Return on Assets (ROA) | 3.16% |
| Return on Invested Capital (ROIC) | 4.41% |
| Return on Capital Employed (ROCE) | 6.85% |
| Revenue Per Employee | 5.15M |
| Profits Per Employee | 245,146 |
| Employee Count | 178 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, Ilex Medical has paid 18.20 million in taxes.
| Income Tax | 18.20M |
| Effective Tax Rate | 28.94% |
Stock Price Statistics
The stock price has decreased by -20.48% in the last 52 weeks. The beta is 0.00, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -20.48% |
| 50-Day Moving Average | 6,539.86 |
| 200-Day Moving Average | 6,359.52 |
| Relative Strength Index (RSI) | 48.65 |
| Average Volume (20 Days) | 1,779 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 917.10 million and earned 43.64 million in profits. Earnings per share was 3.90.
| Revenue | 917.10M |
| Gross Profit | 209.05M |
| Operating Income | 50.07M |
| Pretax Income | 62.88M |
| Net Income | 43.64M |
| EBITDA | 84.78M |
| EBIT | 50.07M |
| Earnings Per Share (EPS) | 3.90 |
Balance Sheet
The company has 244.51 million in cash and 48.96 million in debt, giving a net cash position of 195.55 million or 17.48 per share.
| Cash & Cash Equivalents | 244.51M |
| Total Debt | 48.96M |
| Net Cash | 195.55M |
| Net Cash Per Share | 17.48 |
| Equity (Book Value) | 673.74M |
| Book Value Per Share | 60.09 |
| Working Capital | 445.31M |
Cash Flow
In the last 12 months, operating cash flow was 110.28 million and capital expenditures -24.65 million, giving a free cash flow of 85.63 million.
| Operating Cash Flow | 110.28M |
| Capital Expenditures | -24.65M |
| Free Cash Flow | 85.63M |
| FCF Per Share | 7.65 |
Margins
Gross margin is 22.79%, with operating and profit margins of 5.46% and 4.76%.
| Gross Margin | 22.79% |
| Operating Margin | 5.46% |
| Pretax Margin | 6.86% |
| Profit Margin | 4.76% |
| EBITDA Margin | 9.24% |
| EBIT Margin | 5.46% |
| FCF Margin | 9.34% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -10.63% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.27% |
| Buyback Yield | 0.14% |
| Shareholder Yield | 2.04% |
| Earnings Yield | 6.09% |
| FCF Yield | 11.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
Ilex Medical has an Altman Z-Score of 4.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.03 |
| Piotroski F-Score | 5 |